Literature DB >> 9728995

Symptomatic restenosis after carotid percutaneous transluminal angioplasty.

F Crawley, A Clifton, R S Taylor, M M Brown.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9728995     DOI: 10.1016/S0140-6736(05)60825-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Carotid angioplasty and stenting: current status.

Authors:  D M Pelz; S P Lownie
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

2.  Re: Turk et al and the "how do we spin wingspan?" commentary.

Authors:  C P Derdeyn; M I Chimowitz
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-03       Impact factor: 3.825

3.  The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis.

Authors:  O O Zaidat; R Klucznik; M J Alexander; J Chaloupka; H Lutsep; S Barnwell; M Mawad; B Lane; M J Lynn; M Chimowitz
Journal:  Neurology       Date:  2008-01-30       Impact factor: 9.910

4.  Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial.

Authors:  Leo H Bonati; Jörg Ederle; Dominick J H McCabe; Joanna Dobson; Roland L Featherstone; Peter A Gaines; Jonathan D Beard; Graham S Venables; Hugh S Markus; Andrew Clifton; Peter Sandercock; Martin M Brown
Journal:  Lancet Neurol       Date:  2009-08-28       Impact factor: 44.182

5.  Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial.

Authors:  Leo H Bonati; John Gregson; Joanna Dobson; Dominick J H McCabe; Paul J Nederkoorn; H Bart van der Worp; Gert J de Borst; Toby Richards; Trevor Cleveland; Mandy D Müller; Thomas Wolff; Stefan T Engelter; Philippe A Lyrer; Martin M Brown
Journal:  Lancet Neurol       Date:  2018-06-01       Impact factor: 44.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.